摘要
目的比较远红外线治疗与未治疗对终末期肾脏病患者动静脉内瘘成熟的影响,尤其对老年、糖尿病肾病、高血压肾病患者内瘘血流量的影响。方法回顾性分析南京医科大学附属明基医院肾脏科2014年1月1日至2018年7月30日行自体腕部动静脉内瘘成形术患者91例的临床资料,按术后是否行远红外线照射治疗分为对照组45例(未行远红外线照射治疗)和远红外线组46例(术后24 h行远红外线照射治疗),比较2组术后12周内瘘临床成熟率和动静脉内瘘血流量。每组患者再分为不同亚组,根据年龄分为老年(≥60岁)和青中年(<60岁),根据原发病分为糖尿病肾病和非糖尿病肾病,高血压肾病和非高血压肾病,比较远红外线组与对照组不同亚组间12周后内瘘血流量。结果远红外线组内瘘临床成熟率高于对照组(97.1%vs 84.3%,P<0.05)。术后12周远红外线组内瘘血流量([575.9±8.5)mL/min]较对照组[(541.6±75.5)mL/min]明显增加(P<0.01)。远红外线组老年患者、糖尿病肾病患者、高血压肾病患者内瘘血流量([540.8±50.7)mL/min、(549.3±68.1)mL/min、(565.6±40.3)mL/min]均较对照组[(480.7±51.9)mL/min、(497.3±47.9)mL/min、(505.6±40.3)mL/min]明显增加(P<0.01)。结论远红外线治疗能提高终末期肾脏病患者动静脉内瘘临床成熟率,提高术后12周内瘘血流量,尤其对老年、糖尿病肾病、高血压肾病患者内瘘血流量改善明显。
Objective To compare the effects of far-infrared treatment on the maturation of autogenous arteriovenous fistula(AVF)in end-stage renal disease(ESRD),especially on the blood flow of arteriovenous fistula in elderly,diabetic kidney disease(DKD)and hypertensive patients.Methods A retrospective analysis was made on 91 patients who underwent autogenous arteriove nous fistula operation from January 1,2014 to July 30,2018 in the Renal Disease Center of BenQ Hospital Affiliated to Nanjing Medi cal University,including 45 patients who did not receive far-infrared radiation(the control group)and 46 patients who received far-in frared radiation(the far infrared group).The clinical maturity rate and blood flow of AVF were compared 12 weeks after the operation.Each group was divided into elderly(more than 60 years old)and non-elderly(less than 60 years old)according to age.Ac cording to the primary disease,each group was divided into DKD and non-DKD,hypertensive nephropathy and non-hyper tensive nephropathy.The AVF blood flow of each group was compared after 12 weeks of far infrared treatment.Results The clinical maturity rate of the far infrared group was higher than that of the control group(97.1%vs 84.3%,P<0.05).At 12 weeks af ter operation,the blood flow of the far infrared group[(575.9±8.5)mL/min]was significantly higher than that of the control group[(541.6±75.5)mL/min,P<0.01].Compared with the control group,the blood flow of AVF of the elderly patients,DKD patients and hypertensive nephropathy patients in the far infrared Group[(540.8±50.7)mL/min,(549.3±68.1)mL/min,(565.6±40.3)mL/min]significantly increased[(480.7±51.9)mL/min,(497.3±47.9)mL/min,(505.6±40.3)mL/min,P<0.01].Conclusion Far-infra red treatment can improve the clinical maturity rate of AVF in ESRD and the AVF blood flow in 12 weeks after operation,especially in elderly patients,DKD and hypertensive nephropathy.
作者
余燕婷
王霄剑
张天艳
刘威
高占辉
刘静
季大玺
汪红英
YU Yan-ting;WANG Xiao-Jian;ZHANG Tian-Yan;LIU Wei;GAO Zhan-Hui;LIU Jing;JI Da-xi;WANG Hong-ying(Department of Nephrology,the Affiliated BenQ Hospital of Nanjing Medical University,Nanjing 210019,Jiangsu,China;Department of Ultrasound,BenQ Medical Center,the Affiliated BenQ Hospital of Nanjing Medical University,Nanjing 210019,Jiangsu,China)
出处
《东南国防医药》
2019年第6期598-602,共5页
Military Medical Journal of Southeast China
基金
南京市科技发展计划项目(201715065)
关键词
动静脉内瘘
终末期肾脏病
远红外线治疗
血液透析
arteriovenous fistula
end-stage kidney disease
far-infrared therapy
hemodialysis
